Salarius Pharmaceuticals Inc (NASDAQ:SLRX) shares, rose in value on Friday, August 09, with the stock price up by 17.96% to the previous day’s close as strong demand from buyers drove the stock to $2.43.
Actively observing the price movement in the last trading, the stock closed the session at $2.06. Referring to stock’s 52-week performance, its high was $7.90, and the low was $1.35. On the whole, SLRX has fluctuated by 11.47% over the past month.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that SLRX’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of SLRX currently trading nearly 4.87% and -10.59% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 49.70, while the 7-day volatility ratio is showing 29.64% which for the 30-day chart, stands at 52.82%. Furthermore, Salarius Pharmaceuticals Inc (SLRX)’s beta value is 0.99, and its average true range (ATR) is 0.80.
A comparison of Salarius Pharmaceuticals Inc (SLRX) with its peers suggests the former has fared considerably weaker in the market. SLRX showed an intraday change of 17.96% in last session, and over the past year, it shrunk by -60.01%%.
Data on historical trading for Salarius Pharmaceuticals Inc (NASDAQ:SLRX) indicates that the trading volumes over the past 3 months, they’ve averaged 2.38 million. According to company’s latest data on outstanding shares, there are 0.60 million shares outstanding.
Nearly 6.08% of Salarius Pharmaceuticals Inc’s shares belong to company insiders and institutional investors own 4.03% of the company’s shares. The stock has fallen by -53.27% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the SLRX stock heading into the next quarter.
